These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8841139

  • 1. Three-dimensional structures of HIV-1 and SIV protease product complexes.
    Rose RB, Craik CS, Douglas NL, Stroud RM.
    Biochemistry; 1996 Oct 01; 35(39):12933-44. PubMed ID: 8841139
    [Abstract] [Full Text] [Related]

  • 2. X-ray structure of HIV-1 protease in situ product complex.
    Bihani S, Das A, Prashar V, Ferrer JL, Hosur MV.
    Proteins; 2009 Feb 15; 74(3):594-602. PubMed ID: 18704947
    [Abstract] [Full Text] [Related]

  • 3. Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.
    Rose RB, Craik CS, Stroud RM.
    Biochemistry; 1998 Feb 24; 37(8):2607-21. PubMed ID: 9485411
    [Abstract] [Full Text] [Related]

  • 4. Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity.
    Hoog SS, Towler EM, Zhao B, Doyle ML, Debouck C, Abdel-Meguid SS.
    Biochemistry; 1996 Aug 13; 35(32):10279-86. PubMed ID: 8756683
    [Abstract] [Full Text] [Related]

  • 5. X-ray snapshot of HIV-1 protease in action: observation of tetrahedral intermediate and short ionic hydrogen bond SIHB with catalytic aspartate.
    Das A, Mahale S, Prashar V, Bihani S, Ferrer JL, Hosur MV.
    J Am Chem Soc; 2010 May 12; 132(18):6366-73. PubMed ID: 20397633
    [Abstract] [Full Text] [Related]

  • 6. Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor.
    Laco GS, Schalk-Hihi C, Lubkowski J, Morris G, Zdanov A, Olson A, Elder JH, Wlodawer A, Gustchina A.
    Biochemistry; 1997 Sep 02; 36(35):10696-708. PubMed ID: 9271500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition and catalytic mechanism of HIV-1 aspartic protease.
    Silva AM, Cachau RE, Sham HL, Erickson JW.
    J Mol Biol; 1996 Jan 19; 255(2):321-46. PubMed ID: 8551523
    [Abstract] [Full Text] [Related]

  • 9. On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution.
    Dusková J, Dohnálek J, Skálová T, Petroková H, Vondrácková E, Hradílek M, Konvalinka J, Soucek M, Brynda J, Fábry M, Sedlácek J, Hasek J.
    Acta Crystallogr D Biol Crystallogr; 2006 May 19; 62(Pt 5):489-97. PubMed ID: 16627941
    [Abstract] [Full Text] [Related]

  • 10. A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.
    Bailey D, Cooper JB.
    Protein Sci; 1994 Nov 19; 3(11):2129-43. PubMed ID: 7703859
    [Abstract] [Full Text] [Related]

  • 11. Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.
    Veerapandian B, Cooper JB, Sali A, Blundell TL, Rosati RL, Dominy BW, Damon DB, Hoover DJ.
    Protein Sci; 1992 Mar 19; 1(3):322-8. PubMed ID: 1304340
    [Abstract] [Full Text] [Related]

  • 12. Structural basis for specificity of retroviral proteases.
    Wu J, Adomat JM, Ridky TW, Louis JM, Leis J, Harrison RW, Weber IT.
    Biochemistry; 1998 Mar 31; 37(13):4518-26. PubMed ID: 9521772
    [Abstract] [Full Text] [Related]

  • 13. Alternative native flap conformation revealed by 2.3 A resolution structure of SIV proteinase.
    Wilderspin AF, Sugrue RJ.
    J Mol Biol; 1994 May 27; 239(1):97-103. PubMed ID: 8196050
    [Abstract] [Full Text] [Related]

  • 14. The 80's loop (residues 78 to 85) is important for the differential activity of retroviral proteases.
    Stebbins J, Towler EM, Tennant MG, Deckman IC, Debouck C.
    J Mol Biol; 1997 Apr 04; 267(3):467-75. PubMed ID: 9126830
    [Abstract] [Full Text] [Related]

  • 15. Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries.
    Reid RC, Pattenden LK, Tyndall JD, Martin JL, Walsh T, Fairlie DP.
    J Med Chem; 2004 Mar 25; 47(7):1641-51. PubMed ID: 15027855
    [Abstract] [Full Text] [Related]

  • 16. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
    Towler EM, Gulnik SV, Bhat TN, Xie D, Gustschina E, Sumpter TR, Robertson N, Jones C, Sauter M, Mueller-Lantzsch N, Debouck C, Erickson JW.
    Biochemistry; 1998 Dec 08; 37(49):17137-44. PubMed ID: 9860826
    [Abstract] [Full Text] [Related]

  • 17. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
    Martin PD, Malkowski MG, DiMaio J, Konishi Y, Ni F, Edwards BF.
    Biochemistry; 1996 Oct 08; 35(40):13030-9. PubMed ID: 8855938
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries.
    Beyer BB, Johnson JV, Chung AY, Li T, Madabushi A, Agbandje-McKenna M, McKenna R, Dame JB, Dunn BM.
    Biochemistry; 2005 Feb 15; 44(6):1768-79. PubMed ID: 15697202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.